Impaired synaptic plasticity in mice carrying the Huntington's disease mutation.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Human Molecular Genetics

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/8.5.839PMID 10196373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice.

  1999cited by this paper
• Evidence for specific cognitive deficits in preclinical Huntington's disease.

  1998cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase.

  1996cited by this paper
• Executive and mnemonic functions in early Huntington's disease.

  1996cited by this paper
• Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons.

  1995cited by this paper
• Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form

  1995cited by this paper
• Widespread expression of Huntington's disease gene (IT15) protein product.

  1995cited by this paper
• Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals

  1995cited by this paper
• Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

  1995cited by this paper
• Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases.

  1995cited by this paper
• CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain.

  1995cited by this paper
• Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices.

  1993cited by this paper
• Huntington's disease gene (IT15) is widely expressed in human and rat tissues.

  1993cited by this paper
• Nonuniform probability of glutamate release at a hippocampal synapse.

  1993cited by this paper
• Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection.

  1993cited by this paper
• The probability of transmitter release at a mammalian central synapse

  1993cited by this paper
• Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy

  1992cited by this paper
• Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice.

  1992cited by this paper
• Mechanisms underlying long-term potentiation of synaptic transmission.

  1991cited by this paper

• Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

  2026cites this paper
• Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications.

  2025cites this paper
• Huntingtin plays an essential role in the adult hippocampus.

  2025cites this paper
• An integrated transcriptomic and proteomic map of the mouse hippocampus at synaptic resolution

  2025cites this paper
• Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias

  2025cites this paper
• Motor skill learning modulates striatal extracellular vesicles’ content in a mouse model of Huntington’s disease

  2024cites this paper
• Mild cognitive impairment in Huntington’s disease: challenges and outlooks

  2024cites this paper
• Synaptopodin: a key regulator of Hebbian plasticity

  2024cites this paper
• The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease

  2023cites this paper
• Synaptic Emulation via Ferroelectric P(VDF-TrFE) Reinforced Charge Trapping/Detrapping in Zinc-Tin Oxide Transistor.

  2022cites this paper
• Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington’s disease mice

  2022cites this paper
• Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies

  2022cites this paper
• Huntingtin is essential for synaptic plasticity in the adult hippocampus

  2022cites this paper
• Longitudinal spatial mapping of lipid metabolites reveals pre-symptomatic changes in the hippocampi of Huntington's disease transgenic mice.

  2022cites this paper
• Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease

  2022cites this paper
• Structural Plasticity of the Hippocampus in Neurodegenerative Diseases

  2022cites this paper
• Tauopathies: the role of tau in cellular crosstalk and synaptic dysfunctions.

  2022cites this paper
• Super-resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice.

  2021cites this paper
• A Mechanistic Model of NMDA and AMPA Receptor-Mediated Synaptic Transmission in Individual Hippocampal CA3-CA1 Synapses: A Computational Multiscale Approach

  2021cites this paper
• Huntingtin and the Synapse

  2021cites this paper
• The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration

  2021cites this paper
• C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice

  2021cites this paper
• Development of Hippocampus-Associated Cognitive Dysfunction in Huntington’s Disease Mouse Model

  2021cites this paper
• Development of Hippocampus-Associated Cognitive Dysfunction in Huntington’s Disease Mouse Model

  2021cites this paper
• Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?

  2021cites this paper
• Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

  2021cites this paper
• Do Changes in Synaptic Autophagy Underlie the Cognitive Impairments in Huntington’s Disease?

  2021cites this paper
• Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease

  2020cites this paper
• The Role of the SLC Transporters Protein in the Neurodegenerative Disorders

  2020cites this paper
• Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment

  2020cites this paper
• Striatal network modeling in Huntington’s Disease

  2020cites this paper
• Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders

  2020cites this paper
• Disease-Modification in Huntington’s Disease: Moving Away from a Single-Target Approach

  2019cites this paper
• FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins

  2019cites this paper
• The Onset and Progression of Hippocampal Synaptic Plasticity Deficits in the Q175FDN Mouse Model of Huntington Disease

  2019cites this paper
• Depression in neurodegenerative diseases: Common mechanisms and current treatment options.

  2019cites this paper
• Early synaptic hippocampal deficits in the Q175FDN mouse model of Huntington Disease

  2019influential citation
• Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease.

  2019cites this paper
• Transgenic minipig model of Huntington's disease exhibiting gradually progressing neurodegeneration

  2019cites this paper
• Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease

  2019cites this paper
• Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington’s Disease Progression

  2019cites this paper
• Restoring GABAergic inhibition rescues memory deficits in a Huntington’s disease mouse model

  2018cites this paper
• Evaluation of therapeutic targets for the treatment of behavioral alterations and neuropathology in Huntington’s disease. The role of histone deacetylase 3 and p75 neurotrophin receptor

  2018influential citation
• SAP97‐mediated rescue of NMDA receptor surface distribution in a neuronal model of Huntington's disease

  2018cites this paper
• 6.06 – Excitotoxicity☆

  2018cites this paper
• Study of the mTOR pathway in neurodegenerative diseases: from synapses to genes

  2018cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease

  2018cites this paper
• Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.

  2017cites this paper
• 2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington's disease

  2017cites this paper
• Revisiting the flip side: Long‐term depression of synaptic efficacy in the hippocampus

  2017cites this paper
• Environmental Enrichment Repairs Structural and Functional Plasticity in the Hippocampus

  2017cites this paper
• Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease

  2017cites this paper
• Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease

  2017cites this paper
• More alive than dead: non-apoptotic roles for caspases in neuronal development, plasticity and disease

  2017cites this paper
• Genetic Modifiers of CAG.CTG Repeat Instability in Huntington's Disease Mouse Models

  2017cites this paper
• N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease.

  2017cites this paper
• Electrophysiological approaches to unravel the neurobiological basis of appetite and satiety: use of the multielectrode array as a screening strategy.

  2017cites this paper
• AMPA Receptors as Therapeutic Targets for Neurological Disorders.

  2016cites this paper
• A Stem Cell Model of the Motor Circuit Uncouples Motor Neuron Death from Hyperexcitability Induced by SMN Deficiency.

  2016cites this paper
• Integrative Analysis of Disease Signatures Shows Inflammation Disrupts Juvenile Experience-Dependent Cortical Plasticity

  2016cites this paper
• Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.

  2016cites this paper
• Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington’s Disease

  2016cites this paper
• Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease

  2016cites this paper
• Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.

  2016cites this paper
• Synaptic pathology: A shared mechanism in neurological disease.

  2016cites this paper
• Hippocampal dysfunction defines disease onset in Huntington's disease

  2016cites this paper
• Impairment of Cellular Transcriptional Machinery in Poly(Q) Disorders

  2015cites this paper
• Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.

  2015cites this paper
• Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.

  2015cites this paper
• Hippocampal function is compromised in an animal model of multiple sclerosis.

  2015cites this paper
• YAC128 Huntington's disease transgenic mice show enhanced short-term hippocampal synaptic plasticity early in the course of the disease.

  2014cites this paper
• Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.

  2014cites this paper
• Huntingtin Is Critical Both Pre- and Postsynaptically for Long-Term Learning-Related Synaptic Plasticity in Aplysia

  2014cites this paper
• XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis

  2014cites this paper
• Age-related axonal swellings precede other neuropathological hallmarks in a knock-in mouse model of Huntington's disease.

  2014cites this paper
• Extrasynaptic NMDA receptor involvement in central nervous system disorders.

  2014cites this paper
• Impairment of Cellular Transcriptional Machinery in Poly(Q) Disorders

  2014cites this paper
• Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains

  2014cites this paper
• Amyloid Proteins : A Large Family of Unrelated Proteins with Some Shared Features

  2014cites this paper
• Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease

  2014cites this paper
• Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance

  2014cites this paper
• The role of dopamine in Huntington's disease.

  2014cites this paper
• Choosing an animal model for the study of Huntington's disease

  2013cites this paper
• Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6/1 Mouse Model of Huntington's Disease

  2013cites this paper
• Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.

  2013cites this paper
• Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models

  2013cites this paper
• Noninvasive brain stimulation in Huntington's disease.

  2013cites this paper
• Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease.

  2013cites this paper
• Memory and synaptic deficits in Hip14/DHHC17 knockout mice

  2013cites this paper
• Huntingtin Nuclear Localization: Current Insights into Mechanism and Regulation

  2013cites this paper
• Suppressing aberrant GluN3A expression rescues NMDA receptor dysfunction, synapse loss and motor and cognitive decline in Huntington's disease models

  2013cites this paper
• Synaptic function in the hippocampus in neurodegenerative disease

  2013influential citation
• Cognitive and synaptic dysfunction in a mouse model of Huntington's disease

  2012cites this paper
• "Ectopic" theta oscillations and interictal activity during slow-wave state in the R6/1 mouse model of Huntington's disease.

  2012influential citation
• Cognitive Deficits in Huntington’s Disease: Insights from Animal Models

  2012cites this paper
• Gene expression and behaviour in mouse models of HD.

  2012cites this paper
• Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms

  2012cites this paper
• Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

  2012cites this paper
• What have we learned from gene expression profiles in Huntington's disease?

  2012cites this paper
• Sp1 Regulates Human Huntingtin Gene Expression

  2012cites this paper